119 related articles for article (PubMed ID: 1696538)
1. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors.
Ferrero M; Spyratos F; Le Doussal V; Desplaces A; Rouëssé J
Cytometry; 1990; 11(6):716-24. PubMed ID: 1696538
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
Anal Cell Pathol; 1994 Oct; 7(3):205-15. PubMed ID: 7531483
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA content of fresh tumor specimens using keratin-antibody as second stain for two-parameter analysis.
van der Linden JC; Herman CJ; Boenders JG; van de Sandt MM; Lindeman J
Cytometry; 1992; 13(2):163-8. PubMed ID: 1372209
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by "cross-gating".
Park CH; Kimler BF
Anticancer Res; 1994; 14(1A):29-36. PubMed ID: 7513144
[TBL] [Abstract][Full Text] [Related]
6. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen.
Zarbo RJ; Visscher DW; Crissman JD
Anal Quant Cytol Histol; 1989 Dec; 11(6):391-402. PubMed ID: 2481453
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin subtyping in chordomas and the fetal notochord: an immunohistochemical analysis of aberrant expression.
Naka T; Iwamoto Y; Shinohara N; Chuman H; Fukui M; Tsuneyoshi M
Mod Pathol; 1997 Jun; 10(6):545-51. PubMed ID: 9195570
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood mononuclear cells are a reliable internal standard for the flow cytometric DNA analysis of frozen malignant breast biopsies.
Benn DE; Robinson BG
Cytometry; 1996 Jun; 26(2):161-5. PubMed ID: 8817093
[TBL] [Abstract][Full Text] [Related]
10. Loss of cytokeratins in breast cancer cells using multiparameter DNA flow cytometry is related to both cellular factors and preparation procedure.
Wingren S; Guerrieri C; Frånlund B; Stål O
Anal Cell Pathol; 1995 Oct; 9(3):229-33. PubMed ID: 8562461
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
12. Enhanced assessment of DNA/proliferative index by depletion of tumor infiltrating leukocytes prior to monoclonal antibody gated analysis of tumor cell DNA.
Kenyon NS; Schmittling RJ; Siiman O; Burshteyn A; Bolton WE
Cytometry; 1994 Jun; 16(2):175-83. PubMed ID: 7523044
[TBL] [Abstract][Full Text] [Related]
13. Multiparameter analysis of DNA content and cytokeratin expression in breast carcinoma by laser scanning cytometry.
Clatch RJ; Walloch JL; Foreman JR; Kamentsky LA
Arch Pathol Lab Med; 1997 Jun; 121(6):585-92. PubMed ID: 9199623
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
15. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement.
Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS
Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072
[TBL] [Abstract][Full Text] [Related]
16. DNA index as prognostic factor in breast cancer.
Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
[TBL] [Abstract][Full Text] [Related]
17. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways.
Leers MP; Theunissen PH; Koudstaal J; Schutte B; Ramaekers FC
Cytometry; 1997 Feb; 27(2):179-88. PubMed ID: 9012385
[TBL] [Abstract][Full Text] [Related]
18. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
Fradet Y; Tardif M; Bourget L; Robert J
Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
[TBL] [Abstract][Full Text] [Related]
19. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
20. Assessment and significance of diploid-range epithelial populations in DNA aneuploid breast carcinomas using multi-parametric flow cytometry.
Visscher DW; Sochacki P; Ottosen S; Wykes S; Crissman JD
Anal Cell Pathol; 1995 Jun; 8(4):267-77. PubMed ID: 7577742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
